Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters StreetEvents
$75.00
Provider: GlobalData
$250.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Rhoen Klinikum AG Issues FY 2013 Guidance; Earnings Guidance Below Analysts' Estimates-Conference Call


Thursday, 21 Feb 2013 01:30pm EST 

Rhoen Klinikum AG announced that for fiscal 2013, it expects to see revenues of EUR3.03 billion, subject to a range of plus/minus 2.5%, earnings in a region of EUR325 million in terms of EBITDA, and EUR110 million in terms of consolidated net profit, with both figures subject to a range of plus/minus 5%. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of EUR3.00 billion, EBITDA of EUR343 million and net income of EUR129 million for fiscal 2013. 

Company Quote

23.465
0.035 +0.15%
7:20am EDT